MedPath

Studying the effect of probiotics in the prevention of urinary tract infection among elderlies

Phase 2
Conditions
Prevention of Urinary Tract Infections.
Urinary tract infection, site not specified Use additional code (B95-B98), if desired, to identify infectious agent.
Registration Number
IRCT2016111530906N1
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
53
Inclusion Criteria

The inclusion criteria included elder patients who aged sixty and more, and were admitted to the ICU, and did not have any limitation for taking medicine orally; Exclusion criteria: included the patients who had a history of chemotherapy previously and right now, acute bowel obstruction, short bowel syndrome and acute pancreatitis.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
eukocyturia. Timepoint: Before intervention and a week after completion of taking the capsules. Method of measurement: Urinary analysis.;Urinary tract infection. Timepoint: Before intervention and a week after completion of taking the capsules. Method of measurement: urinary culture.
Secondary Outcome Measures
NameTimeMethod
Mortality. Timepoint: On 30th day of intervention. Method of measurement: Followed up by phone call.
© Copyright 2025. All Rights Reserved by MedPath